Analysed REVIVE THERAPEUTICS LTD (RVVTF:OTCMKTS) News Sources
Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases
11-03-2026
yahoo.com
Revive Therapeutics Announces Closing of First Tranche of Private Placement and Debt Settlement
11-08-2025
yahoo.com
Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study
08-07-2025
yahoo.com
Revive Therapeutics Nears Completion of Nerve Agent Countermeasure Study with Canadian DND
26-06-2025
yahoo.com
What is the current price of REVIVE THERAPEUTICS LTD (RVVTF:OTCMKTS)?
The current price of REVIVE THERAPEUTICS LTD (RVVTF:OTCMKTS) is $0.0303.
REVIVE THERAPEUTICS LTD (RVVTF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of REVIVE THERAPEUTICS LTD (RVVTF:OTCMKTS) since the previous trading day is $-0.0002.
REVIVE THERAPEUTICS LTD (RVVTF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of REVIVE THERAPEUTICS LTD (RVVTF:OTCMKTS) since the previous trading day is -0.6557%.
What is the most recent average sentiment score for REVIVE THERAPEUTICS LTD (RVVTF:OTCMKTS)?
The most recent average sentiment score for REVIVE THERAPEUTICS LTD (RVVTF:OTCMKTS) is 75 out of 100.
What is the most recent average sentiment for REVIVE THERAPEUTICS LTD (RVVTF:OTCMKTS)?
The most recent sentiment for REVIVE THERAPEUTICS LTD (RVVTF:OTCMKTS) is .
SEC-8K** Filing Available For REVIVE THERAPEUTICS LTD (RVVTF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.